GH secretagogues including GHRP-6 are prohibited by WADA (World Anti-Doping Agency) in competitive sports
Individual response guides these decisions
Understanding the exact pathways engaged during the intestinotrophic effects of GLP-2R to expand the absorptive surface area may explain the heterogeneity of the GLP-2 analog response and may provide more therapeutic targets for individuals living with short bowel syndrome, as well as other diseases that impact the small bowel, including atrophy induced by parenteral nutrition, inflammatory bowel diseases, and obesity
Both medications most commonly produce gastrointestinal symptoms: nausea, vomiting, diarrhea and constipation
This is one strategy for reducing the nausea side effects which are commonly experienced with GLP-1 drugs
Of course, there are some who are losing at a much quicker rate, but if thats the result of the medication taking their appetite away completely, I would ask the doctor to decrease the dosage as losing weight too quickly and not fueling your body with nourishing, nutrient-dense foods is a recipe for disaster
